BBO-11818 is a selective, orally bioavailable non-covalent inhibitor that targets KRAS in both the ON and OFF states, has ...

Black Diamond Therapeutics (NASDAQ:BDTX) used a presentation at the 46th annual TD Cowen Healthcare Conference to highlight ...

The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032 ...

BioLife Solutions has executed a successful turnaround by refocusing on core products and divesting non-core assets. Read ...

| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...

During the fourth quarter of 2025, the Fund returned 13.10% (Institutional Shares), outperforming the Russell 3000 Index ...

Master Industrial cooling tower maintenance in Thailand. This guide covers best practices for biofouling, scaling, and corrosion to boost efficiency and cut costs.

Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is a well-recognized cause of bacterial pneumonia, resulting in increased morbidity and mortality worldwide. Traditional antibiotics face ...

The FDA has indexed Faunamor, an antiparasitic and antimicrobial treatment for white spot disease (Ichthyophthirius multifiliis) in ornamental finfish, making the drug legally available in the United ...

BBOT debuted as a publicly traded oncology company developing a differentiated portfolio of three clinical-stage small ...

Recently published Chronic Rhinosinusitis with Nasal Polyps Market Insights report includes a comprehensive understanding of ...

The global healthcare landscape is witnessing a transformative shift in the management of rare genetic disorders. At the forefront of this evolution stands the Hemophilia Therapeutics Market. This ...